Risk of progression in 213 patients. Patients were residents of southeastern Minnesota in whom monoclonal gammopathy of undetermined significance (MGUS) of IgM class was diagnosed from 1960 through 1994. Risk is shown with and without reduction of uninvolved immunoglobulins. Numbers at bottom of horizontal axis are numbers of patients at risk at each interval.